We are live on ! Find out more
OPK icon

Opko Health

259 hedge funds and large institutions have $1.19B invested in Opko Health in 2016 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 81 increasing their positions, 93 reducing their positions, and 48 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding in top 10

Funds holding in top 10: 46 (+2)

3% more capital invested

Capital invested by funds: $1.16B → $1.19B (+$34.6M)

1.11% less ownership

Funds ownership: 21.18%20.08% (-1.1%)

5% less funds holding

Funds holding: 273259 (-14)

13% less repeat investments, than reductions

Existing positions increased: 81 | Existing positions reduced: 93

21% less first-time investments, than exits

New positions opened: 38 | Existing positions closed: 48

29% less call options, than puts

Call options by funds: $67.2M | Put options by funds: $95.2M

Holders
259
Holders Change
-14
Holders Change %
-5.13%
% of All Funds
6.88%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.16%
New
38
Increased
81
Reduced
93
Closed
48
Calls
$67.2M
Puts
$95.2M
Net Calls
-$28M
Net Calls Change
+$17.3M

OPK Hedge Fund Activity: Q1 2016 in Review

259 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Opko Health (OPK) for Q1 2016, worth a combined $1.19B — up 3% from $1.16B a quarter earlier.

Sellers outnumbered buyers: 48 funds closed out of OPK and 38 opened new positions — a net loss of 10 holders — while 93 trimmed existing stakes and 81 added.

The largest buyer was Morgan Stanley, adding an estimated $22.6M. The largest seller was Barclays, cutting an estimated $16.4M.

  • 259 institutional investors held Opko Health (OPK) as of Q1 2016, down from 273 in Q4 2015.
  • Funds reported $1.19B of Opko Health stock for Q1 2016, up 3% quarter-over-quarter.
  • 38 funds opened new Opko Health positions in Q1 2016 and 48 closed out, a net change of -10 holders.
  • The largest Opko Health buyer in Q1 2016 was Morgan Stanley, an estimated $22.6M added.
  • The largest Opko Health seller in Q1 2016 was Barclays, an estimated $16.4M sold.

Based on aggregated 13F filings for Q1 2016.